procarbazine has been researched along with aclarubicin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S | 1 |
Alberto, P; Mermillod, B; Zulian, GB | 1 |
Adachi, T; Asano, K; Hoshijima, T; Izumi, K; Kimura, I; Murakami, M; Sezaki, T; Takahashi, I; Tsubota, T | 1 |
Hatake, K; Imagawa, S; Izumi, T; Kuriki, K; Miura, Y; Muroi, K; Ogawa, Y; Ohtsuki, T; Ohya, K; Saito, K; Yoshida, M | 1 |
4 other study(ies) available for procarbazine and aclarubicin
Article | Year |
---|---|
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Vincristine | 1992 |
[Clinical study on chemotherapy for multiple myeloma: Part IV: Prognostic factors related to long survival].
Topics: Aclarubicin; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Middle Aged; Multiple Myeloma; Naphthacenes; Nitrosourea Compounds; Prednisolone; Procarbazine; Prognosis; Vincristine | 1988 |
Therapy-related leukemia with a novel 21q22 rearrangement.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 21; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Proto-Oncogene Proteins; Transcription Factors; Vincristine | 1996 |